State of the science on mild cognitive impairment (MCI)

被引:299
|
作者
Anderson, Nicole D. [1 ,2 ]
机构
[1] Univ Toronto, Dept Psychol, Rotman Res Inst, Baycrest Hlth Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Rotman Res Inst, Baycrest Hlth Sci, Toronto, ON, Canada
关键词
Amyloid; biomarkers; exercise and diet interventions; memory strategy training; mild cognitive impairment; neuroimaging; neuropsychological assessment; tau; HEALTHY OLDER-ADULTS; QUALITY-OF-LIFE; FAMILIARITY-BASED MEMORY; ALZHEIMERS-DISEASE; PERIRHINAL CORTEX; DEPRESSIVE SYMPTOMS; ENTORHINAL CORTEX; PHYSICAL-ACTIVITY; AMERICAN ACADEMY; SYDNEY MEMORY;
D O I
10.1017/S1092852918001347
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and dementia, and affects 10-15% of the population over the age of 65. The failure of drug trials in Alzheimer's disease (AD) treatment has shifted researchers' focus toward delaying progression from MCI to dementia, which would reduce the prevalence and costs of dementia profoundly. Diagnostic criteria for MCI increasingly emphasize the need for positive biomarkers to detect preclinical AD. The phenomenology of MCI comprises lower quality-of-life, greater symptoms of depression, and avoidant coping strategies including withdrawal from social engagement. Neurobiological features of MCI are hypoperfusion and hypometabolism in temporoparietal cortices, medial temporal lobe atrophy particularly in rhinal cortices, elevated tau and phosphorylated tau and decreased A(42) in cerebrospinal fluid, and brain A(42) deposition. Elevated tau can be identified in MCI, particularly in the entorhinal cortex, using positron emission tomography, and analysis of signal complexity using electroencephalography or magnetoencephalography holds promise as a biomarker. Assessment of MCI also relies on cognitive screening and neuropsychological assessment, but there is an urgent need for standardized cognitive tests to capitalize on recent discoveries in cognitive neuroscience that may lead to more sensitive measures of MCI. Cholinesterase inhibitors are frequently prescribed for MCI, despite the lack of evidence for their efficacy. Exercise and diet interventions hold promise for increasing reserve in MCI, and group psychoeducational programs teaching practical memory strategies appear effective. More work is needed to better understand the phenomenology and neurobiology of MCI, and how best to assess it and delay progression to dementia.
引用
收藏
页码:78 / 87
页数:10
相关论文
共 50 条
  • [41] A review of the effectiveness of memory interventions in mild cognitive impairment (MCI)
    Stott, Joshua
    Spector, Aimee
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (04) : 526 - 538
  • [42] The rate of conversion to dementia in mild cognitive impairment (MCI) patients
    Prodan, L.
    Draghici, A.
    Filip, C. Roman
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 111 - 111
  • [43] The neuropathological profile of mild cognitive impairment (MCI): a systematic review
    Stephan, B. C. M.
    Hunter, S.
    Harris, D.
    Llewellyn, D. J.
    Siervo, M.
    Matthews, F. E.
    Brayne, C.
    MOLECULAR PSYCHIATRY, 2012, 17 (11) : 1056 - 1076
  • [44] The neuropathological profile of mild cognitive impairment (MCI): a systematic review
    B C M Stephan
    S Hunter
    D Harris
    D J Llewellyn
    M Siervo
    F E Matthews
    C Brayne
    Molecular Psychiatry, 2012, 17 : 1056 - 1076
  • [45] Cerebral metabolic heterogeneity in patients with mild cognitive impairment (MCI).
    Drzezga, A
    Minoshima, S
    Lautenschlager, N
    Reimenschneider, M
    Kurz, A
    Schwaiger, M
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 64P - 64P
  • [46] Predictors of progression from mild cognitive impairment (MCI) to dementia
    Crum, TA
    Lagari, V
    Luis, C
    Barker, WW
    Loewenstein, D
    Duara, R
    NEUROBIOLOGY OF AGING, 2004, 25 : S382 - S382
  • [47] The neurocog: A screening test for detecting mild cognitive impairment (MCI)
    Duara, R
    Amador, B
    Barker, WW
    Munoz, E
    Rubenstein, N
    Loewenstein, DA
    NEUROLOGY, 2005, 64 (06) : A365 - A366
  • [48] SERVICE USE AND FAMILY CAREGIVING OF MILD COGNITIVE IMPAIRMENT (MCI)
    Weaver, R. H.
    Brossoie, N.
    Potter, E.
    Savla, J.
    Roberto, K. A.
    GERONTOLOGIST, 2015, 55 : 728 - 728
  • [49] Early Detection of Mild Cognitive Impairment (MCI) in Primary Care
    Sabbagh, Marwan N.
    Boada, M.
    Borson, S.
    Chilukuri, M.
    Dubois, B.
    Ingram, J.
    Iwata, A.
    Porsteinsson, A. P.
    Possin, K. L.
    Rabinovici, G. D.
    Vellas, B.
    Chao, S.
    Vergallo, A.
    Hampel, H.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2020, 7 (03): : 165 - 170
  • [50] The Goteborg MCI study:: mild cognitive impairment is a heterogeneous condition
    Nordlund, A
    Rolstad, S
    Hellström, P
    Sjögren, M
    Hansen, S
    Wallin, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (11): : 1485 - 1490